Medical Advocates

ARV/HAART
/cART
  Switching Therapy 
              

General Reports 
Switching from PI-Based Therapy
Switching from NRTI -Based Therapy
Treatment Failure Predictors   




 

 

HAART Main Page Main New/Newsworthy  Home Page      

Last Update:  January 22, 2018  
 Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader

 
General Reports
 

     Journal Papers, Abstracts, and Commentaries
 
 
New Strategies of ARV: the Road to Simplification.
de Miguel Buckley R, Montejano R, Stella-Ascariz N, Arribas JR.
Curr HIV/AIDS Rep
. 2018 Jan 20.
Abstract

Brief Report: High Need to Switch cART or Comedication With the Initiation of DAAs in Elderly HIV/HCV-Coinfected Patients.
Smolders EJ, Smit C, T M M de Kanter C,.ry ak
J Acquir Immune Defic Syndr. 2017
Abstract

Quality of Life of HIV-infected Patients Who Switch Antiretroviral Medication Due to Side Effects or Other Reasons.
Maiese EM, Johnson PT, Bancroft T, et al
Curr Med Res Opin
. 2016 Aug 23:1-24.
Abstract

Antiretroviral Treatment Switching and Its Association With Economic Outcomes and Adverse Treatment Effects Among Commercially Insured and Medicaid-Enrolled Patients With HIV in the United States.
Korsnes JS, Goodwin BB, Murray M, Candrilli SD.
Ann Pharmacother. 2016 Jul 20.
Abstract

Comparison of Antiretroviral Regimens: Adverse Effects and Tolerability Failure that Cause Regimen Switching.
Kim MJ, Kim SW, Chang HH,  et al
Infect Chemother. 2015 Dec;47(4):231-8.
Abstract

CD4+ and viral load outcomes of antiretroviral therapy switch strategies after virologic failure of combination antiretroviral therapy in perinatally HIV-infected youth in the United States.
Fairlie L, Karalius B, Patel K,  et al
AIDS
. 2015 Jul 15
Abstract

The influence of patient beliefs and treatment satisfaction on the discontinuation of current first-line antiretroviral regimens.
Casado JL, Marín A, Romero V, et al

HIV Med
. 2015 Jul 6
Abstract

Successful antiretroviral therapy by using unusual antiretroviral combinations in heavily pre-treated patients: two case reports.
Taramasso L, Dentone C, Alessandrini A, et al
Int J STD AIDS
. 2014 Oct 20.
Abstract

Improved virological and immunological efficacy of resistance-guided switch in antiretroviral therapy: a Frankfurt HIV cohort analysis.
Wolf T, Fuß B, Khaykin P, Berger A, et al
Med Microbiol Immunol. 2014 Aug 23
Abstract

Switch strategies in antiretroviral therapy regimens.
Van den Eynde E, Podzamczer D.

Expert Rev Anti Infect Ther
. 2014 Jul 30:1.
Abstract

FULL-TEXT ARTICLE
High Level of Viral Suppression and Low Switch Rate to Second-Line Antiretroviral Therapy among HIV-Infected Adult Patients Followed over Five Years: Retrospective Analysis of the DART Trial.
Kityo C, Gibb DM, Gilks CF,  et al
PLoS One. 2014 Mar 13;9(3):e90772.
Paper

FULL=TEXT ARTICLE
Switching HIV Treatment in Adults Based on CD4 Count Versus Viral Load Monitoring: A Randomized, Non-Inferiority Trial in Thailand.
Jourdain G, Le Cœur S, Ngo-Giang- et al

PLoS Med
. 2013 Aug;10(8):e1001494.
Paper

Modeling clinical endpoints as a function of time of switch to second-line ART with incomplete data on switching times.
Johnson BA, Ribaudo H, Gulick RM, Eron JJ Jr.
Biometrics. 2013 Jul 17.
Abstract

Efficacy of Antiretroviral Therapy Switch in HIV-Infected Patients: A 10-Year Analysis
of the EuResist Cohort.
Oette M, Schülter E, Rosen-Zvi M,  et al
Intervirology. 2012;55(2):160-6.
Abstract

FULL-TEXT ARTICLE
Optimal Antiviral Switching to Minimize Resistance Risk in HIV Therapy.
Luo R, Piovoso MJ, Martinez-Picado J, Zurakowski R.
PLoS One. 2011;6(11):e27047..
Paper

Using Administrative Claims Data to Estimate Virologic Failure Rates among Human Immunodeficiency
Virus-Infected Patients with Antiretroviral Regimen Switches.
Broder MS, Juday T, Chang EY,  et al

Med Decis Making
. 2011 Apr 21.
Abstract

Improvement in Vitamin D Deficiency Following Antiretroviral Regime Change:
Results from the MONET Trial.
Fox J, Peters B, Prakash M, et al

AIDS Res Hum Retroviruses. 2010 Sep 21.
Abstract

Antiretroviral regimens for patients with HIV who fail first-line antiretroviral therapy.
Humphreys EH, Chang LW, Harris J.

Cochrane Database Syst Rev
. 2010 Jun 16;6:CD006517.
Abstract

FULL-TEXT ARTICLE
Rates and Reasons for Early Change of First HAART in HIV-1-Infected Patients in
7 Sites throughout the Caribbean and Latin America

Cesar C, Bryan E. Shephed BE,
Krolewiecki AJ, et al
PLoS One
.
Jun 2010 2010
Paper

Optimal monitoring strategies for guiding when to switch first-line antiretroviral therapy
regimens for treatment failure in adults and adolescents living with HIV in low-resource
settings.
Chang LW, Harris J, Humphreys E.

Cochrane Database Syst Rev. 2010 Apr 14;4:CD008494
Abstract

The frequency and reasons for antiretroviral switching with specific antiretroviral
associations: the SWITCH study.
Davidson I, Beardsell H, Smith B, et al
 
Antiviral Res
. 2010 Mar 4.
Abstract

Switching HIV therapies: competing host and viral factors.
Kilby JM. 
Lancet. 2010 Jan 12.
Abstract

 
     Conference Reports, Abstracts, and Posters
 
 

Reasons for switching highly active antiretroviral therapy (HAART) regimens among
HIV/AIDS patients in low-resource settings: the case of Mbagathi District Hospital,
Kenya

Kocholla L, Wangai M, Kusu N,. et al
(4th IAS Conference)
Abstract


 
Switching from PI-Based Regimens
 

     Journal Papers, Abstracts, and Commentaries

 
Long-term efficacy of second-line treatment of HIV infection after class change
f ollowing virological failure on protease inhibitor-based therapy.
Brunner J, Seybold U, Gunsenheimer-Bartmeyer B, et al

Dtsch Med Wochenschr
. 2010 Jun;135(23):1166-1170.
Abstract

Improvement of HAART-associated insulin resistance and dyslipidemia after replacement
of protease inhibitors with abacavir.
Walli RK, Michl GM, Bogner JR, Goebel FD.
Eur J Med Res. 2001 Oct 29;6(10):413-21
Abstract


 
Switching from NRTI=Based Regimens
 

     Journal Papers, Abstracts, and Commentaries

  Response to Antiretroviral Treatment After Failure of NNRTI plus NRTIs-Based Therapy.
Data from the ARCA Collaborative Group.
Seminari E, De Silvestri A, Meini G,  et al
Curr HIV Res. 2012 May 10.
Abstract

 
Treatment Failure Predictors
 

     Journal Papers, Abstracts, and Commentaries
 
  Predictors of treatment failure during highly active antiretroviral therapy (racing trial).
Masuhr A, Mueller M, Simon V, et al
Eur J Med Res. 2002 Aug 30;7(8):341-6.
Abstract 
 


HAART Main Page Main New/Newsworthy  Home Page      

Switching Therapy